By Finance Pulse in financial performance —

Titan Pharmaceuticals Reports $763K Q3 Net Loss

Titan Pharmaceuticals reveals a $763,000 net loss in Q3, translating to a 83 cents per share loss. Discover the impact on Titan's financial performance.

A sleek, modern graph showing a downward trend, with a subtle color palette of blues and greys, symb
Titan Pharmaceuticals Reports $763K Q3 Net Loss

Titan Pharmaceuticals reported a net loss of $763,000 for Q3, equating to a loss of 83 cents per share.

Source